
Ultragenyx Pharmaceutical Inc.
USD30.68
-0.09 (-0.29%)
CEO
Emil D. Kakkis
IPO Date
2014-01-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$30.77
Prev. Close
$30.77
Day Low
$30.19
Day High
$31.16
52W Low
$18.29
52W High
$42.37
Market Cap
$3.02B
Volume
3.92M
| 1 Oct 2024 |
| Cantor Fitzgerald |
| Overweight |
| Overweight |
| maintain |
| 26 Sept 2024 | RBC Capital | Outperform | Outperform | maintain |
| 20 Sept 2024 | Cantor Fitzgerald | Overweight | Overweight | maintain |
| 16 Sept 2024 | Cantor Fitzgerald | Overweight | Overweight | maintain |
| 5 Aug 2024 | Barclays | Overweight | Overweight | maintain |
| 2 Aug 2024 | Goldman Sachs | Buy | Buy | maintain |
| 2 Aug 2024 | Wells Fargo | Overweight | Overweight | maintain |